News

Published on 29 Aug 2023 on Zacks via Yahoo Finance

Athira Pharma, Inc. (ATHA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now


Article preview image

The price trend for Athira Pharma, Inc. (ATHA) has been bearish lately and the stock has lost 10.8% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support.

While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock.

Understanding Hammer Chart and the Technique to Trade It

NASDAQ.ATHA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Athira Pharma Insider Ups Holding By 111% During Year

From what we can see, insiders were net buyers in Athira Pharma, Inc.'s (NASDAQ:ATHA ) during the...

Simply Wall St. · via Yahoo Finance 18 Dec 2024

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In...

Athira Pharma's Alzheimer's Candidate Fails To Improve Cognition And Function In Patients With Mi...

Benzinga · via Yahoo Finance 19 Aug 2024

retail investors who own 35% along with institutions invested in Athira Pharma,...

Key Insights The considerable ownership by retail investors in Athira Pharma indicates that they ...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

One Athira Pharma Insider Raised Their Stake In The Previous Year

Viewing insider transactions for Athira Pharma, Inc.'s (NASDAQ:ATHA ) over the last year, we see ...

Simply Wall St. via Yahoo Finance 24 Apr 2024

Is Stryker (SYK) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 29 Mar 2024

Athira Pharma, Inc. (ATHA) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 28 Feb 2024

With 36% ownership, Athira Pharma, Inc. (NASDAQ:ATHA) has piqued the interest of...

Key Insights Significantly high institutional ownership implies Athira Pharma's stock price is...

Simply Wall St. · via Yahoo Finance 25 Jan 2024

Athira Pharma Insiders Placed Bullish Bets Worth US$556.3k

Generally, when a single insider buys stock, it is usually not a big deal. However, when several ...

Simply Wall St. via Yahoo Finance 15 Nov 2023

Athira Pharma, Inc. (ATHA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

The price trend for Athira Pharma, Inc. (ATHA) has been bearish lately and the stock has lost 10....

Zacks via Yahoo Finance 29 Aug 2023

FDA Rejects ImmunityBio's (IBRX) Bladder Cancer Therapy Filing

Shares of ImmunityBio IBRX were down 55.1% on Thursday after management announced that FDA issued...

Zacks via Yahoo Finance 12 May 2023